OAK RIDGE, Tenn., Dec. 12, 2019 — Oak Ridge National Laboratory and five leading building equipment industries will collaborate to improve the energy performance of heating, air conditioning and ventilation systems and investigate climate-friendly alternative refrigerants.
Buildings use 40 percent of America’s primary energy and 75 percent of its electricity, which can jump to 80 percent when a majority of the population is at home using heating or cooling systems and the seasons reach their extremes.
Researchers at Oak Ridge National Laboratory demonstrated that metal foam enhances the evaporation process in thermal conversion systems and enables the development of compact HVAC&R units.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Scientists at Oak Ridge National Laboratory studying quantum communications have discovered a more practical way to share secret messages among three parties, which could ultimately lead to better cybersecurity for the electric grid
An online tool developed by researchers at Oak Ridge National Laboratory provides architects and engineers a fast and efficient way to assess the performance of a building’s envelope design before construction begins.
Scientists at Oak Ridge National Laboratory have developed a low-cost, printed, flexible sensor that can wrap around power cables to precisely monitor electrical loads from household appliances to support grid operations.
Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data. Applying this technique to science problems can help unearth historically elusive solutions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.